Craig McCabe, MD
Ophthalmology · Murfreesboro, TNNPI 1396747325
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $48,650 of the $80,956 with a category attached, or 60.1%. AbbVie accounts for 78.9% of it on its own, with 34 other manufacturers making up the rest. Among ophthalmology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 463 payments — averaging $174.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$64K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$5K
- Alcon$4K
- Johnson & Johnson Surgical Vision, Inc.$3K
- Eyevance Pharmaceuticals LLC$1K
- Genentech USA, Inc.$366
- plus $3K from 29 others
Across 1 payment — averaging $128.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$128
What the payments were for
- Consulting fees$2,9384%
- Speaking & faculty fees$48,65060%
- Travel & lodging$14,19818%
- Food & beverage$14,93418%
- Education$1030%
- Entertainment$1330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DURYSTA$47,371
- LUMIGAN$11,782
- COMBIGAN$6,535
- LOTEMAX SM$4,943
- Tecnis 1-piece IOL$1,556
- Tecnis 3-piece IOL$1,556
- Tecnis Symphony IOL$1,556
- Tecnis Symphony Toric IOL$1,556
- Flarex$1,250
- Tecnis IOL$625
- XEN GLAUCOMA TREATMENT SYSTEM$364
- DAILIES$312
- Rocklatan$264
- Clareon$248
- AcrySof IQ VIVITY IOL$171
- NGENUITY$148
- Tecnis Simplicity$147
- OMNI(R) SURGICAL SYSTEM (US)$135
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$122
- EYLEA$118
How this compares
$80,956 in reported general payments places this provider in the 95th percentile of 323 ophthalmology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 140 | $69,034 |
| RocklatanNetarsudil Mesylat/Latanoprost | 55 | $33,665 |
| CombiganBrimonidine Tartrate/Timolol | 31 | $14,585 |
| Prednisolone Acetate | 289 | $10,041 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 46 | $8,099 |
| Latanoprost | 466 | $6,001 |
| Ketorolac Tromethamine | 198 | $4,914 |
| ProlensaBromfenac Sodium | 12 | $4,177 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 209 | $3,765 |
| Bromfenac Sodium | 16 | $3,460 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 15 | $3,453 |
| TafluprostTafluprost/Pf | 11 | $3,444 |
| Brimonidine Tartrate | 68 | $3,245 |
| Travoprost | 24 | $3,020 |
| Ofloxacin | 195 | $2,702 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Combigan | $63,897 | $83,620171 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan | $247 | $33,66555 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa | $5,437 | $4,17712 claims |
| AlconSimbrinza | $3,662 | $3,45315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 323 ophthalmology providers in Tennessee.
Other ophthalmology in Murfreesboro
- Deborah ShermanNashville$3M
- Melissa ToyosMemphis$1.3M
- Rolando ToyosMemphis$809K
- Brian BiesmanNashville$630K
- Brian FowlerMemphis$206K
- Edward ChaumNashville$158K
- Brian JerkinsMemphis$150K
- James FreemanMemphis$141K
- Michael PattersonCrossville$138K
- John FreemanMemphis$136K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.